Skip to Content

M 274 (Tamoxifen 20 mg)

Pill with imprint M 274 is White, Round and has been identified as Tamoxifen citrate 20 mg. It is supplied by Mylan Pharmaceuticals Inc..

Tamoxifen is used in the treatment of breast cancer, metastatic; breast cancer, adjuvant; breast cancer; breast cancer, male; breast cancer, palliative (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for M 274

Tamoxifen citrate 20 mg M 274
Tamoxifen citrate 20 mg M 274 Front
Tamoxifen citrate 20 mg M 274 Back
Tamoxifen citrate 20 mg M 274

Tamoxifen citrate

M 274
20 mg
10.00 mm
Prescription only
Drug Class:
Selective estrogen receptor modulators
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
lactose anhydrous
silicon dioxide
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.